The news directly pertains to Morgan Stanley as its price target has been lowered by Oppenheimer. However, the Outperform rating is maintained which indicates that the analyst still expects the stock to do better than the market. This could have a neutral impact on the stock as the lowered price target might cause some investors to sell, but the maintained Outperform rating could also attract new investors.